secwatch.observer — SEC 8-K summary
======================================

Issuer:     ESTABLISHMENT LABS HOLDINGS INC. (ESTA)
CIK:        0001688757
Form:       8-K
Filed at:   2023-01-11T23:59:59+00:00
Accession:  0001688757-23-000008
Event type: regulatory
Sentiment:  positive
Materiality: 0.72
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Estab. Labs ready to submit PMA Module 4 for Motiva implants in Q1 2023; targets $500M revenue by FY2026
--------------------------------------------------------------------------------

- Notified FDA it is ready to submit Module 4 of pre-market approval for Motiva Implants in the U.S.
- Expects to file Module 4 during Q1 2023, working with FDA on optimal timing.
- CEO to present at 41st J.P. Morgan Healthcare Conference on January 12, 2023.
- Company targets $500 million in annual revenue for fiscal year 2026.
- Presentation materials furnished as Exhibit 99.1; forward-looking statements noted.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1688757/000168875723000008/0001688757-23-000008-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1688757/000168875723000008/esta-20230111.htm
  HTML page:      https://secwatch.observer/filing/0001688757-23-000008

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer